Xenon Pharmaceuticals, Inc. (XENE)
54.39
-1.61
(-2.88%)
USD |
NASDAQ |
May 15, 16:00
52.65
-1.74
(-3.20%)
After-Hours: 20:00
Xenon Pharmaceuticals EPS Diluted (Quarterly) : -1.171 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.2496 |
| Alkermes Plc | -0.40 |
| Edesa Biotech, Inc. | -0.4939 |
| ProMIS Neurosciences, Inc. | -1.263 |
| Tyra Biosciences, Inc. | -0.6366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -102.30M |
| Total Expenses (Quarterly) | 102.30M |
| Enterprise Value | 4.170B |
| Earnings Yield | -8.65% |
| Normalized Earnings Yield | -8.650 |